MedPath

A clinical trial to study of analgesic and hemodynamic effect of nalbuphine vs fentanyl, a randomized double blind Interventional Study On Cardiac Surgical Patients

Not Applicable
Conditions
Health Condition 1: I39- Endocarditis and heart valve disorders in diseases classified elsewhere
Registration Number
CTRI/2019/10/021537
Lead Sponsor
Department of anesthesiologySMS medical college jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Either sex

2. Age group 18-65yrs

3 .Body weight 40-70kg

4. ASA Grade II &lll

5. Scheduled for cardiac surgery on cardiopulmonary bypass

Exclusion Criteria

1.Patients not willing to participate in study

2.Uncooperative patients

3.Patients with history of drug allergy

4.Patients with pre-existing, Asthma, Renal or Hepatic dysfunction

5.Morbid obese patient

6.Pregnancy/Lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess and compare hemodynamic variables from baseline at different time interval in both groups. <br/ ><br>Heart rate <br/ ><br>Systolic blood pressure <br/ ><br>Diastolic blood pressure <br/ ><br>Mean Arterial Pressure <br/ ><br>central venous pressure <br/ ><br> <br/ ><br>Timepoint: Data will be recorded baseline (before induction), just after intubation, 5 min and 15 min, 30 min after intubation nd after that 5 min before going on pump, 5 min after going on pump, every 30 min till shifted to icu.
Secondary Outcome Measures
NameTimeMethod
1.To asses and compare BIS guided total requirement of analgesic drug in bothgroups <br/ ><br>2.To assess and compare the time required for first rescue analgesic in both group in postoperative period after extubation according to VAS score. <br/ ><br>3.To compare side effects and complications of both drugs. <br/ ><br>Timepoint: After extubation ,post operative analgesia evaluted by visual analogue scale (VAS)in every 30 mins till vas more then 3
© Copyright 2025. All Rights Reserved by MedPath